SGLT2is, GLP-1s Display Reno-Protective Benefit in Sickle Cell Disease

Preliminary findings demonstrate an improvement in eGFR slope in nearly all patients with SCD after treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.

Related Keywords

Illinois ,United States ,American ,Sunr Srivastava ,Santoshl Saraf , ,University Of Illinois Santoshl Saraf ,University Of Illinois Chicago ,Protection With ,Newer Antidiabetic Agents ,Patients With Diabetes ,Chronic Kidney Disease ,Scientific Statement From ,American Heart Association ,